Collectively, these findings suggest that the activation of MEK1 through the ERK pathway, through its involvement in TDP-43 phosphorylation, neuronal signalling, and oligodendrocyte function, may represent a contributing mechanism underlying ALS pathology and a potential target for therapeutic intervention. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.